StonvexLoading…
StonvexCore line items from GRAL's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q3 2026 (Est.) Expected 2026-08-10 | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|---|
Revenue | $43.97M | $40.78M | $147.17M | $103.58M | $67.38M |
Operating Income | Not available | $-135.76M | $-562.16M | $-437.75M | $-312.46M |
Net Income | Not available | $-93.19M | $-408.35M | $-309.18M | $-113.98M |
EPS (Diluted) | $-2.80 | $-2.29 | $-11.11 | $-8.73 | $-6.28 |
Total Assets | Not available | $2.80B | $2.92B | $2.60B | $2.70B |
Total Liabilities | Not available | $302.79M | $344.15M | $361.07M | $387.91M |
Cash & Equivalents | Not available | $69.34M | $249.73M | $126.89M | $127.43M |
Free Cash Flow OCF − CapEx | Not available | $-87.49M | $-299.92M | $-236.04M | $-172.41M |
Shares Outstanding | Not available | 41.13M | 40.33M | 36.16M | 36.05M |